Accelerating antiviral drug discovery: lessons from COVID-19
National Institute for Health Research · University of Oxford · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
184
total citations
- FWCI
- 34.36
- Percentile
- 100%
- References
- 277
Citations per year
Authors
8- AVAnnette von DelftCorresponding
National Institute for Health Research, University of Oxford
- MDMatthew D. Hall
National Institutes of Health, National Center for Advancing Translational Sciences
- ADAnn D. Kwong
- LALisa A. Purcell
VIR Biotechnology (United States)
- KSKumar Singh Saikatendu
Takeda (United States)
Topics & keywords
Topics
Keywords
- Drug discovery
- Coronavirus disease 2019 (COVID-19)
- Pandemic
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Bottleneck
- Antiviral drug
- 2019-20 coronavirus outbreak
- Coronavirus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- WTWellcome TrustAward: 224021
- NINational Institute for Health and Care Research
- NINational Institutes of HealthAwards: COVID-19, U19AI171399
- NINational Institute of Allergy and Infectious DiseasesAwards: COVID-19, U19AI171399
- NCNational Center for Advancing Translational Sciences
- MRMoonshot Research and Development Program